Prognostic factors of early recurrence after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

doi:10.12998/wjcc.v12.i27.6057

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1581)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

674

Figures (1-2)

124

Tables (1-4)

119

Sum=945

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

192

Download

241

Sum=433

Publishing Process of This Article

Item

Count

Browse

Download

125

Sum=169

Sep 26, 2024 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Sep 26, 2024; 12(27): 6057-6069
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6057

Full Size Figure Download Figure

Figure 2 Kaplan–Meier analysis of overall survival comparing patients in the progression-free survival < 1-year group and progression-free survival ≥ 1-year group. The favorable progression-free survival (PFS) group had a significantly longer overall survival compared to the unfavorable PFS group.

Citation: Chen CY, Huang TH, Lee LW, Lung J, Ou YC, Hung CH, Chuang HC, Chen MC, Wang TY. Prognostic factors of early recurrence after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Clin Cases 2024; 12(27): 6057-6069
URL: https://www.wjgnet.com/2307-8960/full/v12/i27/6057.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i27.6057